Altoida partners with Hospital Clínic Barcelona on innovative biomarker study

We are excited to announce the collaboration between Altoida and Hospital Clínic Barcelona on a groundbreaking study exploring plasma and digital biomarkers for the early detection of Alzheimer’s disease in primary care.

This innovative pilot study aims to recruit 400 participants over the next 18 months, combining blood tests with Altoida’s cognitive assessments to improve diagnostic accuracy and streamline patient care. As Marc Jones, CEO of Altoida, remarked, “This pilot project will provide invaluable insights and is just the beginning.”

Congratulations to both teams! Research and innovation are essential to the future of cognitive healthcare!

Read the press release